Cargando…
Potent and Selective BACE-1 Peptide Inhibitors Lower Brain Aβ Levels Mediated by Brain Shuttle Transport
Therapeutic approaches to fight Alzheimer's disease include anti-Amyloidβ (Aβ) antibodies and secretase inhibitors. However, the blood-brain barrier (BBB) limits the brain exposure of biologics and the chemical space for small molecules to be BBB permeable. The Brain Shuttle (BS) technology is...
Autores principales: | Ruderisch, Nadine, Schlatter, Daniel, Kuglstatter, Andreas, Guba, Wolfgang, Huber, Sylwia, Cusulin, Carlo, Benz, Jörg, Rufer, Arne Christian, Hoernschemeyer, Joerg, Schweitzer, Christophe, Bülau, Tina, Gärtner, Achim, Hoffmann, Eike, Niewoehner, Jens, Patsch, Christoph, Baumann, Karlheinz, Loetscher, Hansruedi, Kitas, Eric, Freskgård, Per-Ola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652008/ https://www.ncbi.nlm.nih.gov/pubmed/28923680 http://dx.doi.org/10.1016/j.ebiom.2017.09.004 |
Ejemplares similares
-
Cargo Delivery into the Brain by in vivo identified Transport Peptides
por: Urich, Eduard, et al.
Publicado: (2015) -
Brain Shuttle Neprilysin reduces central Amyloid-β levels
por: Campos, Christopher R., et al.
Publicado: (2020) -
Trafficking of Endogenous Immunoglobulins by Endothelial Cells at the Blood-Brain Barrier
por: Villaseñor, Roberto, et al.
Publicado: (2016) -
Targeting neuronal lysosomal dysfunction caused by β-glucocerebrosidase deficiency with an enzyme-based brain shuttle construct
por: Gehrlein, Alexandra, et al.
Publicado: (2023) -
Multicellular Self-Assembled Spheroidal Model of the Blood Brain Barrier
por: Urich, Eduard, et al.
Publicado: (2013)